Mangoceuticals, Inc. Common Stock (MGRX) — Working Capital to Net Assets Ratio
Mangoceuticals, Inc. Common Stock (MGRX) has a Working Capital to Net Assets ratio of -9.2% as of June 2026. Working capital of $-1.15 Million (current assets of $245.69K minus current liabilities of $1.40 Million) is measured against net assets of $12.52 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Mangoceuticals, Inc. Common Stock fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Mangoceuticals, Inc. Common Stock Working Capital to Net Assets (2021–2025)
This chart shows how Mangoceuticals, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at -9.2%, reflecting working capital of $-1.15 Million against net assets of $12.52 Million USD. For the complete balance sheet picture, see Mangoceuticals, Inc. Common Stock assets under control.
Annual Working Capital to Net Assets for Mangoceuticals, Inc. Common Stock (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Mangoceuticals, Inc. Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Mangoceuticals, Inc. Common Stock debt and liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 4.3% | $656.87K | $15.20 Million | $1.55 Million | $890.57K | ▲ +14.0 pp |
| 2024 | -9.7% | $-1.35 Million | $13.95 Million | $75.59K | $1.43 Million | ▼ -88.1 pp |
| 2023 | 78.4% | $607.38K | $774.75K | $818.46K | $211.08K | ▲ +7.7 pp |
| 2022 | 70.7% | $434.03K | $614.03K | $694.61K | $260.58K | ▼ -29.3 pp |
| 2021 | 100.0% | $-16.72K | $-16.72K | $22.55K | $39.27K | — |